link
Bookmarks
Ovarian Cancer
Brad Perry, MD; Paige Bennett, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
1
7
2
2

KEY FACTS

  • Imaging

    • Top Differential Diagnoses

      • Diagnostic Checklist

        TERMINOLOGY

        • Definitions

          • Primary ovarian carcinoma
            • Epithelial (90%), stromal (6%), germ cell (3%)
            • Initial mass involves ovary ± fallopian tubes
          • Metastatic spread
            • Can involve pelvic &/or paraaortic nodes
            • Peritoneum
              • Can lead to encasement of reproductive/abdominal organs by malignant tumor
            • Distant metastases include liver, lung

        IMAGING

        • F-18 FDG PET/CT Findings

          • MR Findings

            DIFFERENTIAL DIAGNOSIS

              PATHOLOGY

              • General Features

                • Staging, Grading, & Classification

                  CLINICAL ISSUES

                  • Presentation

                    • Demographics

                      • Natural History & Prognosis

                        • Treatment

                          DIAGNOSTIC CHECKLIST

                          • Image Interpretation Pearls

                            • Reporting Tips

                              Selected References

                              1. Khiewvan B et al: An update on the role of PET/CT and PET/MRI in ovarian cancer. Eur J Nucl Med Mol Imaging. ePub, 2017
                              2. Limei Z et al: Accuracy of positron emission tomography/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis. Int J Gynecol Cancer. 23(4):598-607, 2013
                              3. Palomar A et al: Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels. Mol Imaging Biol. 14(1):123-9, 2012
                              4. Chung HH et al: Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. Eur J Nucl Med Mol Imaging. 34(4):480-6, 2007
                              5. Mangili G et al: Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. Eur J Nucl Med Mol Imaging. 34(5):658-66, 2007
                              6. Thrall MM et al: Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol. 105(1):17-22, 2007
                              7. Kurosaki H et al: Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment. Ann Nucl Med. 20(3):171-4, 2006
                              8. Murakami M et al: Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer. Int J Gynecol Cancer. 16 Suppl 1:99-107, 2006
                              9. Havrilesky LJ et al: FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 97(1):183-91, 2005
                              10. MRI, CT, and PET/CT for Ovarian Cancer Detection and Adnexal Lesion Characterization
                              Related Anatomy
                              Loading...
                              Related Differential Diagnoses
                              Loading...
                              References
                              Tables

                              Tables

                              KEY FACTS

                              • Imaging

                                • Top Differential Diagnoses

                                  • Diagnostic Checklist

                                    TERMINOLOGY

                                    • Definitions

                                      • Primary ovarian carcinoma
                                        • Epithelial (90%), stromal (6%), germ cell (3%)
                                        • Initial mass involves ovary ± fallopian tubes
                                      • Metastatic spread
                                        • Can involve pelvic &/or paraaortic nodes
                                        • Peritoneum
                                          • Can lead to encasement of reproductive/abdominal organs by malignant tumor
                                        • Distant metastases include liver, lung

                                    IMAGING

                                    • F-18 FDG PET/CT Findings

                                      • MR Findings

                                        DIFFERENTIAL DIAGNOSIS

                                          PATHOLOGY

                                          • General Features

                                            • Staging, Grading, & Classification

                                              CLINICAL ISSUES

                                              • Presentation

                                                • Demographics

                                                  • Natural History & Prognosis

                                                    • Treatment

                                                      DIAGNOSTIC CHECKLIST

                                                      • Image Interpretation Pearls

                                                        • Reporting Tips

                                                          Selected References

                                                          1. Khiewvan B et al: An update on the role of PET/CT and PET/MRI in ovarian cancer. Eur J Nucl Med Mol Imaging. ePub, 2017
                                                          2. Limei Z et al: Accuracy of positron emission tomography/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis. Int J Gynecol Cancer. 23(4):598-607, 2013
                                                          3. Palomar A et al: Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels. Mol Imaging Biol. 14(1):123-9, 2012
                                                          4. Chung HH et al: Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. Eur J Nucl Med Mol Imaging. 34(4):480-6, 2007
                                                          5. Mangili G et al: Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. Eur J Nucl Med Mol Imaging. 34(5):658-66, 2007
                                                          6. Thrall MM et al: Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol. 105(1):17-22, 2007
                                                          7. Kurosaki H et al: Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment. Ann Nucl Med. 20(3):171-4, 2006
                                                          8. Murakami M et al: Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer. Int J Gynecol Cancer. 16 Suppl 1:99-107, 2006
                                                          9. Havrilesky LJ et al: FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 97(1):183-91, 2005
                                                          10. MRI, CT, and PET/CT for Ovarian Cancer Detection and Adnexal Lesion Characterization